Provider review

Hims & Hers reviewed

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.

Hims & Hers scores 26.6 out of 100 on our published Value Score formula for tirzepatide. It charges $548 a month all-in at 10 mg/week, and raises the price as the dose rises.

What it wins

It holds no computed category at this build. For reference, NexLife, our #1 pick, charges $129 a month for tirzepatide at every dose (as of November 6, 2026).

Where it sits on tirzepatide

Hims & Hers is number 25 of 27 rankable tirzepatide programs on all-in monthly cost, at $548. The program immediately below it is LillyDirect (Zepbound) Official site at $449, $99 cheaper. The next one up is LifeMD Official site at $597.

$1,188 a year separates them. What does Hims & Hers disclose that LillyDirect (Zepbound) does not? It names its compounding pharmacy, which the cheaper option also does — so the premium is not buying disclosure. Full head-to-head.

Hims & Hers charges a flat $548 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay. The company publishes no price at 5, 7.5, 12.5, 15 mg, so those doses are left blank rather than estimated.

2.557.51012.515mg/week$548$548
Tirzepatide holds at $548 a month across every dose — a flat line. 4 of 6 doses have no published price; those gaps are shown as gaps.

The gaps matter more than the headline. Hims & Hers publishes nothing at 5, 7.5, 12.5, 15 mg per week, so a reader cannot establish what the middle of a titration costs without asking. We leave those blank rather than interpolating.

How Hims & Hers ranks at each rung of the tirzepatide ladder
DoseHims & Hers priceRank at this doseField median at this dose
2.5 mg$54830 of 31$297
5 mgnot published——
7.5 mgnot published——
10 mg$54825 of 27$299
12.5 mgnot published——
15 mgnot published——

Its standing is not constant across the ladder — it ranks differently at different doses, which is exactly what a single headline figure conceals.

Where it sits on semaglutide

Hims & Hers is number 28 of 29 rankable semaglutide programs on all-in monthly cost, at $453. The program immediately below it is NovoCare Pharmacy (Wegovy) Official site at $349, $104 cheaper. The next one up is Ro (Ro Body) Official site at $498.

$1,248 a year separates them. What does Hims & Hers disclose that NovoCare Pharmacy (Wegovy) does not? It names its compounding pharmacy, which the cheaper option also does — so the premium is not buying disclosure. Full head-to-head.

Hims & Hers charges a flat $453 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay. The company publishes no price at 0.5, 1, 1.7 mg, so those doses are left blank rather than estimated.

0.250.511.72.4mg/week$453$453
Semaglutide holds at $453 a month across every dose — a flat line. 3 of 5 doses have no published price; those gaps are shown as gaps.

The gaps matter more than the headline. Hims & Hers publishes nothing at 0.5, 1, 1.7 mg per week, so a reader cannot establish what the middle of a titration costs without asking. We leave those blank rather than interpolating.

How Hims & Hers ranks at each rung of the semaglutide ladder
DoseHims & Hers priceRank at this doseField median at this dose
0.25 mg$45332 of 32$199
0.5 mgnot published——
1 mgnot published——
1.7 mgnot published——
2.4 mg$45328 of 29$199

Its standing is not constant across the ladder — it ranks differently at different doses, which is exactly what a single headline figure conceals.

What would move it

24 programs are priced below it on tirzepatide. Reaching the three lowest all-in tirzepatide prices on record would take a price at or under $179 a month — a cut of $369 from where it stands. Alternatively, an independent checkout capture would lift its evidence component without any price change.

Why it scores what it does

Of 26.6 points, 16.1 of a possible 70 come from price measured against the $126 category floor, 10.5 of 15 from evidence status (reported), 0 of 10 from dose policy and 0 of 5 from membership. Its weakest component is its dose policy.

The evidence term is worth dwelling on. Hims & Hers's figure is reported — sourced from dated third-party reporting; first-party capture pending. An independent checkout capture would raise that component without the price changing at all, so this score is a floor rather than a ceiling.

What you are actually buying

Hims & Hers carries a membership of $149 a month on top of the medication, shipping billed at $5, commitment terms of Membership month-to-month ($39 first month), cancellation on Cancel anytime.

It names its compounding pharmacy — Brand fulfillment (Wegovy, oral Wegovy, Zepbound) + partner pharmacy, recorded as Brand channel. That is checkable against state board licensing and FDA inspection history before you order, and it is the single most useful thing a program can disclose. Availability is stated as 50 states.

Against the field

29 of 36 programs charge no membership, 8 name their pharmacy, 19 price flat. Hims & Hers: $149 membership, pharmacy named, priced by dose.

What to establish before enrolling

Drawn from what this specific record does not contain:

  • What tirzepatide costs at 5, 7.5, 12.5, 15 mg per week.
  • Whether a twelve-month tirzepatide rate exists and what it is.
  • What semaglutide costs at 0.5, 1, 1.7 mg per week.
  • Whether a twelve-month semaglutide rate exists and what it is.

In writing, before you pay.

On the record: The membership is the number that moves the math: a $299 Wegovy pen becomes ~$453/month all-in. Compare against going to NovoCare or LillyDirect directly.

Who should pick it, and who should not

Consider Hims & Hers if you intend to check the compounding pharmacy's licence and inspection history yourself.

Look elsewhere if you expect to settle at a high dose, because the price rises with the dose; you may pause or skip months, since the $149 membership continues regardless; price is your main criterion, since it runs $422 a month above the category floor.

At $548 a month it is $419 above NexLife's $129, the price of our #1 pick — $5,028 a year for what it discloses and includes.

Questions

Is Hims & Hers worth it?

At $548 a month all-in it scores 26.6 out of 100 on our published formula, against a category floor of $126. Whether that is worth it depends on whether its dose policy, pharmacy disclosure and cancellation terms justify the gap — the review above lays out both sides.

How much does Hims & Hers cost in total?

$548 a month all-in at 10 mg/week, or $6,576 across twelve months billed monthly. All-in means the medication plus every mandatory recurring fee.

What is cheaper than Hims & Hers?

The next program below it on all-in monthly tirzepatide cost is LillyDirect (Zepbound) at $449 a month, $99 less per month. Hims & Hers ranks 25 of 27 on price.

Is Hims & Hers legitimate?

It names its compounding pharmacy — Brand fulfillment (Wegovy, oral Wegovy, Zepbound) + partner pharmacy — which means its licensing and FDA inspection history can be checked independently before you order.

How do I cancel Hims & Hers?

Cancel anytime

Figures from the Hims & Hers record, dataset v2026-11-10. Hims & Hers official site. Prices change; verify at checkout. Compounded tirzepatide and semaglutide are not FDA-approved products.